| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $183K | +50.0% |
| R&D Expense | $3.0M | -30.1% |
| SG&A Expense | $7.1M | -6.3% |
| Operating Income | -$9.9M | -495.5% |
| Pre-tax Income | -$7.2M | -280.8% |
| Net Income | -$7.2M | -356.3% |
| EPS (Basic) | -$0.74 | -21.3% |
| EPS (Diluted) | -$0.74 | -21.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | +977.3% |
| Accounts Receivable | $323K | +267.0% |
| Current Assets | $3.8M | -87.4% |
| Total Assets | $4.7M | -87.5% |
| Current Liabilities | $19.6M | -44.6% |
| Total Liabilities | $19.6M | -57.3% |
| Stockholders' Equity | -$15.5M | +2.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.0M | -134.8% |
| Capital Expenditures | $48K | +0.0% |
| Financing Cash Flow | $11.2M | +104.1% |
| Free Cash Flow | -$9.1M | -133.2% |